Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2080839 | Drug Discovery Today | 2009 | 13 Pages |
Abstract
Osteoarthritis (OA) is associated with cartilage degeneration and an accompanying inflammatory syndrome of the synovium in addition to alteration of the subchondral bone. The molecular and cellular events involved in OA have only partially been elucidated. This review provides a global view of the physiopathology of OA, as well as non-pharmacological and pharmacological treatments for the disorder. An update on surgical treatments and their indications is given with an orientation towards the management of OA and cartilage repair by cell-based regenerative therapies. These promising biological technologies will, potentially, play a major role in the treatment of cartilage-associated diseases.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Johann Clouet, Claire Vinatier, Christophe Merceron, Marianne Pot-vaucel, Yves Maugars, Pierre Weiss, Gaël Grimandi, Jérôme Guicheux,